HIV New Product Introduction Toolkit

Last updated: October 2024 Within the ARV market, there are a number of reference price lists to help inform the latest costs of adult...

This tool was developed to support national HIV programs and ministries of health to estimate and compare the cost of the following two...

GHSC-PSM strategically sources and manages quality-assured commodities like essential medicines and supplies for HIV/AIDS, malaria,...

Low- and middle-income countries (LMIC) currently experience low testing coverage in the face of increasing demand to meet the needs of...

Fillable report and presentation template for governments to adjust as needed for introduction of pediatric DTG. English | French

This policy brief outlines key considerations to facilitate effective transition to more clinically appropriate regimens as optimal...

Given their role in funding and procuring commodities, it is important to align product introduction plans with donor budgetary processes...

For more than 20 years, the MSF Access Campaign has been monitoring the patent barriers, prices and availability of antiretroviral...

The Global Fund has established framework agreements with manufacturers of antiretroviral medicines with the aim to achieve lower prices...

This memo highlights the benefits, market considerations, and potential for savings of three ARV optimization opportunities. Proactively...

This Toolkit contains various practical tools and guidance to support countries as they introduce point-of-care (POC) HIV technologies...

As national programs introduce new, generic ARVs they must plan how and when the new product will be phased-in to ensure smooth and...

This memo outlines some of the challenges and benefits of ARV optimization, highlighting product transition successes through...

This presentation from the 2016 International AIDS Society Conference outlines key approaches to product introduction, including working...